Early developmental elevations of brain kynurenic acid impair cognitive flexibility in adults: reversal with galantamine.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Neuroscience

• Publication date

  2013-05-15

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/j.neuroscience.2013.01.063PMID 23395862PMCID PMC3622758
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Pre‐ and postnatal exposure to kynurenine causes cognitive deficits in adulthood

  2012cited by this paper
• Exposure to kynurenic acid during adolescence produces memory deficits in adulthood.

  2012cited by this paper
• From Revolution to Evolution: The Glutamate Hypothesis of Schizophrenia and its Implication for Treatment

  2012cited by this paper
• Kynurenine 3-monooxygenase polymorphisms: relevance for kynurenic acid synthesis in patients with schizophrenia and healthy controls.

  2012cited by this paper
• Impaired kynurenine pathway metabolism in the prefrontal cortex of individuals with schizophrenia.

  2011cited by this paper
• Blockade of NMDA GluN2B receptors selectively impairs behavioral flexibility but not initial discrimination learning

  2011cited by this paper
• Deficits in attentional control: cholinergic mechanisms and circuitry-based treatment approaches.

  2011cited by this paper
• Age Dependency of Inhibition of α7 Nicotinic Receptors and Tonically Active N-Methyl-d-aspartate Receptors by Endogenously Produced Kynurenic Acid in the Brain

  2011cited by this paper
• Long-lasting effects of inescapable-predator stress on brain tryptophan metabolism and the behavior of juvenile mice

  2011cited by this paper
• Acute elevations of brain kynurenic acid impair cognitive flexibility: normalization by the alpha7 positive modulator galantamine

  2011cited by this paper
• Fluctuations in Endogenous Kynurenic Acid Control Hippocampal Glutamate and Memory

  2011cited by this paper
• The development of neural synchrony and large-scale cortical networks during adolescence: relevance for the pathophysiology of schizophrenia and neurodevelopmental hypothesis.

  2011cited by this paper
• Administration of kynurenine during adolescence, but not during adulthood, impairs social behavior in rats.

  2011cited by this paper
• Glutamate as a marker of cognitive function in schizophrenia: a proton spectroscopic imaging study at 4 Tesla.

  2011cited by this paper
• Transient Inactivation of the Neonatal Ventral Hippocampus Permanently Disrupts the Mesolimbic Regulation of Prefrontal Cholinergic Transmission: Implications for Schizophrenia

  2011cited by this paper
• Maternal infection and schizophrenia: implications for prevention.

  2011cited by this paper
• Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes.

  2011cited by this paper
• Altered levels of glutamatergic receptors and Na+/K+ ATPase-α1 in the prefrontal cortex of subjects with schizophrenia.

  2011cited by this paper
• Selective deficits in spatial working memory in the neonatal ventral hippocampal lesion rat model of schizophrenia.

  2010cited by this paper
• Differential Contributions of the Primate Ventrolateral Prefrontal and Orbitofrontal Cortex to Serial Reversal Learning

  2010cited by this paper
• Cortical kynurenic acid bi-directionally modulates prefrontal glutamate levels as assessed by microdialysis and rapid electrochemistry.

  2010cited by this paper
• Neonatal infection with neurotropic influenza A virus induces the kynurenine pathway in early life and disrupts sensorimotor gating in adult Tap1-/- mice.

  2010cited by this paper
• Differential Regulation of α7 Nicotinic Receptor Gene (CHRNA7) Expression in Schizophrenic Smokers

  2009cited by this paper
• Disruption of mesolimbic regulation of prefrontal cholinergic transmission in an animal model of schizophrenia and normalization by chronic clozapine treatment

  2009cited by this paper
• Kynurenine pathway in psychosis: evidence of increased tryptophan degradation

  2009cited by this paper
• Astrocyte‐derived kynurenic acid modulates basal and evoked cortical acetylcholine release

  2009cited by this paper
• CNTRICS final task selection: control of attention.

  2009cited by this paper
• The Astrocyte-Derived α7 Nicotinic Receptor Antagonist Kynurenic Acid Controls Extracellular Glutamate Levels in the Prefrontal Cortex

  2009cited by this paper
• Chronic infusion of PCP via osmotic mini-pumps: a new rodent model of cognitive deficit in schizophrenia characterized by impaired attentional set-shifting (ID/ED) performance.

  2009cited by this paper
• In-vivo rodent models for the experimental investigation of prenatal immune activation effects in neurodevelopmental brain disorders.

  2009cited by this paper
• Prefrontal cognitive systems in schizophrenia : Towards human genetic brain mechanisms

  2009cited by this paper
• L-kynurenine treatment alters contextual fear conditioning and context discrimination but not cue-specific fear conditioning.

  2009cited by this paper
• Attentional set-shifting ability in first-episode and established schizophrenia: Relationship to working memory.

  2009cited by this paper
• Neonatal ventral hippocampus lesions disrupt extra-dimensional shift and alter dendritic spine density in the medial prefrontal cortex of juvenile rats.

  2008cited by this paper
• The construct of attention in schizophrenia.

  2008cited by this paper
• Galantamine for the treatment of cognitive impairments in people with schizophrenia.

  2008cited by this paper
• Differential effects of inactivation of the orbitofrontal cortex on strategy set-shifting and reversal learning.

  2008cited by this paper
• Neonatal functional blockade of the entorhinal cortex results in disruption of accumbal dopaminergic responses observed in latent inhibition paradigm in adult rats

  2007cited by this paper
• Elevations of endogenous kynurenic acid produce spatial working memory deficits.

  2007cited by this paper
• Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions.

  2007cited by this paper
• Competitive Antagonism between the Nicotinic Allosteric Potentiating Ligand Galantamine and Kynurenic Acid at α7* Nicotinic Receptors

  2007cited by this paper
• Response inhibition and cognitive flexibility in schizophrenia with and without comorbid substance use disorder.

  2007cited by this paper
• Galantamine improves cognition in schizophrenic patients stabilized on risperidone.

  2006cited by this paper
• Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder.

  2006cited by this paper
• Multiple Dopamine Receptor Subtypes in the Medial Prefrontal Cortex of the Rat Regulate Set-Shifting

  2006cited by this paper
• enetics of Chromosome 15 q 13-q 14 in Schizophrenia

  2006cited by this paper
• Treatment of cognitive deficits in schizophrenia.

  2006cited by this paper
• Schizophrenia as an inflammation-mediated dysbalance of glutamatergic neurotransmission

  2006cited by this paper
• Selective lesions of the nucleus basalis magnocellularis impair cognitive flexibility.

  2006cited by this paper
• Galantamine--a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer's disease.

  2006cited by this paper
• Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum

  2005cited by this paper
• Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits.

  2005cited by this paper
• Genetic mechanisms of psychosis: in vivo and postmortem genomics.

  2005cited by this paper
• Regulation of axon growth in vivo by activity-based competition

  2005cited by this paper
• Endogenous kynurenic acid disrupts prepulse inhibition.

  2004cited by this paper
• Stability of set-shifting and planning abilities in patients with schizophrenia.

  2004cited by this paper
• Glutamate receptors in the rat medial prefrontal cortex regulate set-shifting ability.

  2003cited by this paper
• The neurobiological consequences of early stress and childhood maltreatment.

  2003cited by this paper
• Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat.

  2003cited by this paper
• Cognitive performance in schizophrenia patients assessed before and following the first psychotic episode.

  2003cited by this paper
• Galantamine Is an Allosterically Potentiating Ligand of Neuronal Nicotinic but Not of Muscarinic Acetylcholine Receptors

  2003influential reference
• Prefrontal Dopamine D1 Receptors and Working Memory in Schizophrenia

  2002cited by this paper
• Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia.

  2001cited by this paper
• Relation of prefrontal cortex dysfunction to working memory and symptoms in schizophrenia.

  2001cited by this paper
• The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications.

  2001cited by this paper
• Increased cortical kynurenate content in schizophrenia.

  2001cited by this paper
• Performance of patients with schizophrenia on the Wisconsin Card Sorting Test (WCST).

  2001cited by this paper
• Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection

  2001cited by this paper
• Low muscarinic receptor binding in prefrontal cortex from subjects with schizophrenia: a study of Brodmann's areas 8, 9, 10, and 46 and the effects of neuroleptic drug treatment.

  2001cited by this paper
• The Brain Metabolite Kynurenic Acid Inhibits α7 Nicotinic Receptor Activity and Increases Non-α7 Nicotinic Receptor Expression: Physiopathological Implications

  2001cited by this paper
• Medial Frontal Cortex Mediates Perceptual Attentional Set Shifting in the Rat

  2000cited by this paper
• Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

  2000cited by this paper
• Blockade of neuronal activity alters spine maturation of dentate granule cells but not their dendritic arborization.

  1999influential reference
• Decreased protein level of nicotinic receptor alpha7 subunit in the frontal cortex from schizophrenic brain.

  1999cited by this paper
• Modulatory role of presynaptic nicotinic receptors in synaptic and non-synaptic chemical communication in the central nervous system.

  1999cited by this paper
• Increased dopamine transmission in schizophrenia: relationship to illness phases.

  1999cited by this paper
• NMDA receptor mRNA correlation with antemortem cognitive impairment in schizophrenia.

  1996cited by this paper
• Fluorimetric micro-determination of kynurenic acid, an endogenous blocker of neurotoxicity, by high-performance liquid chromatography.

  1988cited by this paper
• The continuing problem of false positives in repeated measures ANOVA in psychophysiology: a multivariate solution.

  1987influential reference

• Tryptophan Metabolism in Developmental Origins of Health and Disease.

  2025cites this paper
• Functional Impairments in Learning and Signal Propagation Following Prenatal Kynurenine Treatment in Mice

  2025cites this paper
• Escitalopram alters tryptophan metabolism, plasma lipopolysaccharide, and the inferred functional potential of the gut microbiome in deer mice showing compulsive-like rigidity

  2025cites this paper
• Neuroprotection effects of kynurenic acid-loaded micelles for the Parkinson’s disease models

  2024cites this paper
• Galantamine-Memantine Combination in the Treatment of Parkinson’s Disease Dementia

  2024cites this paper
• Inhibition of midbrain cholinergic neurons impairs decision-making strategies during reversal learning

  2024cites this paper
• Neuroactive Kynurenines as Pharmacological Targets: New Experimental Tools and Exciting Therapeutic Opportunities

  2024cites this paper
• Maternal Inflammation with Elevated Kynurenine Metabolites Is Related to the Risk of Abnormal Brain Development and Behavioral Changes in Autism Spectrum Disorder

  2023cites this paper
• Tryptophan challenge in individuals with schizophrenia and healthy controls: acute effects on circulating kynurenine and kynurenic acid, cognition and cerebral blood flow

  2023cites this paper
• Schizophrenia Etiological Factors and Their Correlation with the Imbalance of the Immune System: An Update

  2023cites this paper
• LC–MS/MS-based quantification of tryptophan, kynurenine, and kynurenic acid in human placental, fetal membranes, and umbilical cord samples

  2023cites this paper
• Developmental Exposure to Kynurenine Affects Zebrafish and Rat Behavior

  2023cites this paper
• Probiotics Show Promise as a Novel Natural Treatment for Neurological Disorders.

  2023cites this paper
• Enhancing the resolution of behavioral measures: Key observations during a forty year career in behavioral neuroscience.

  2022cites this paper
• Prefrontal α7nAChR Signaling Differentially Modulates Afferent Drive and Trace Fear Conditioning Behavior in Adolescent and Adult Rats

  2021cites this paper
• Kynurenine emerges from the shadows - Current knowledge on its fate and function.

  2021cites this paper
• A Potential Interface between the Kynurenine Pathway and Autonomic Imbalance in Schizophrenia

  2021cites this paper
• A single prenatal lipopolysaccharide injection has acute, but not long‐lasting, effects on cerebral kynurenine pathway metabolism in mice

  2021cites this paper
• Galantamine-Memantine Combination and Kynurenine Pathway Enzyme Inhibitors in the Treatment of Neuropsychiatric Disorders

  2021cites this paper
• Kynurenic acid in neurodegenerative disorders—unique neuroprotection or double‐edged sword?

  2021cites this paper
• Addiction and the kynurenine pathway: A new dancing couple?

  2021cites this paper
• Prenatal THC exposure raises kynurenic acid levels in the prefrontal cortex of adult rats.

  2020cites this paper
• Immune-Kynurenine Pathways and the Gut Microbiota-Brain Axis in Anxiety Disorders.

  2020cites this paper
• Gut Biofactory—Neurocompetent Metabolites within the Gastrointestinal Tract. A Scoping Review

  2020cites this paper
• Profiling of Tryptophan Metabolic Pathways in the Rat Fetoplacental Unit during Gestation

  2020cites this paper
• Neurological and cognitive significance of probiotics: a holy grail deciding individual personality.

  2020cites this paper
• Exposure to Elevated Embryonic Kynurenine in Rats: Sex-dependent Learning and Memory Impairments in Adult Offspring.

  2020cites this paper
• Meta-analysis of randomized controlled trials of galantamine in schizophrenia: significant cognitive enhancement.

  2020cites this paper
• Activation of alpha7 nicotinic and NMDA receptors is necessary for performance in a working memory task

  2020cites this paper
• Microglial Function in the Effects of Early-Life Stress on Brain and Behavioral Development

  2020cites this paper
• The ‘Yin’ and the ‘Yang’ of the kynurenine pathway: excitotoxicity and neuroprotection imbalance in stress-induced disorders

  2019cites this paper
• Assessment of Prenatal Kynurenine Metabolism Using Tissue Slices: Focus on the Neosynthesis of Kynurenic Acid in Mice

  2019cites this paper
• In a Model of Neuroinflammation Designed to Mimic Delirium, Quetiapine Reduces Cortisol Secretion and Preserves Reversal Learning in the Attentional Set Shifting Task

  2019cites this paper
• Does kynurenic acid act on nicotinic receptors? An assessment of the evidence

  2019cites this paper
• Altered motor, anxiety-related and attentional task performance at baseline associate with multiple gene copies of the vesicular acetylcholine transporter and related protein overexpression in ChAT::Cre+ rats

  2019cites this paper
• Transplantation of microbiota from drug-free patients with schizophrenia causes schizophrenia-like abnormal behaviors and dysregulated kynurenine metabolism in mice

  2019cites this paper
• Reduced adolescent risk-assessment and lower nicotinic beta-2 expression in rats exposed to nicotine through lactation by forcedly drinking dams.

  2019cites this paper
• Plant-Derived Alkaloids

  2018cites this paper
• Prenatal kynurenine treatment in rats causes schizophrenia-like broad monitoring deficits in adulthood

  2018cites this paper
• Restraint Stress during Pregnancy Rapidly Raises Kynurenic Acid Levels in Mouse Placenta and Fetal Brain

  2017cites this paper
• 3‐Furan‐2‐yl‐N‐p‐tolyl‐acrylamide, a positive allosteric modulator of the &agr;7 nicotinic receptor, reverses schizophrenia‐like cognitive and social deficits in rats

  2017cites this paper
• Probiotic, Prebiotic, and Brain Development

  2017cites this paper
• Kynurenine pathway metabolism and the microbiota‐gut‐brain axis

  2017cites this paper
• Preferential Disruption of Prefrontal GABAergic Function by Nanomolar Concentrations of the α7nACh Negative Modulator Kynurenic Acid

  2017cites this paper
• Kynurenic Acid in Schizophrenia: A Systematic Review and Meta-analysis

  2017cites this paper
• Elevated kynurenine pathway metabolism during neurodevelopment: Implications for brain and behavior.

  2017cites this paper
• The kynurenine pathway in schizophrenia and bipolar disorder.

  2017cites this paper
• Immunopathology of the Nervous System

  2017cites this paper
• Towards an Immunophenotype of Schizophrenia: Progress, Potential Mechanisms, and Future Directions

  2017cites this paper
• Oral administration of a specific kynurenic acid synthesis (KAT II) inhibitor attenuates evoked glutamate release in rat prefrontal cortex.

  2017cites this paper
• Cholinergic circuits in cognitive flexibility.

  2017cites this paper
• Kynurenine pathway and cognitive impairments in schizophrenia: Pharmacogenetics of galantamine and memantine

  2016cites this paper
• Repeated LPS Injection Induces Distinct Changes in the Kynurenine Pathway in Mice

  2016cites this paper
• Cognition and Emotions in Recurrent Depressive Disorders - The Role of Inflammation and the Kynurenine Pathway.

  2016cites this paper
• Serotonergic and Cholinergic Strategies as Potential Targets for the Treatment of Schizophrenia.

  2016cites this paper
• The Immunology of Behavior ‖ Towards an Immunophenotype of Schizophrenia : Progress , Potential Mechanisms , and Future Directions Running Title : Schizophrenia Immunophenotype

  2016cites this paper
• Imbalanced kynurenine pathway in schizophrenia and depression : immunological and genetic aspects

  2016cites this paper
• Positive allosteric modulators of alpha 7 nicotinic acetylcholine receptors reverse ketamine-induced schizophrenia-like deficits in rats.

  2016cites this paper
• Astrocytes as Pharmacological Targets in the Treatment of Schizophrenia

  2016cites this paper
• Exposure to Kynurenic Acid during Adolescence Increases Sign-Tracking and Impairs Long-Term Potentiation in Adulthood

  2015cites this paper
• Kynurenines and Brain Development

  2015cites this paper
• Elevated levels of kynurenic acid during gestation produce neurochemical, morphological, and cognitive deficits in adulthood: implications for schizophrenia.

  2015cites this paper
• The effects of postnatal alcohol exposure and galantamine on the context pre-exposure facilitation effect and acetylcholine efflux using in vivo microdialysis.

  2015cites this paper
• The Role of Kynurenine Pathway Metabolites in Neuropsychiatric Disorders

  2015cites this paper
• Positive allosteric modulation of alpha 7 nicotinic acetylcholine receptors enhances recognition memory and cognitive flexibility in rats.

  2015cites this paper
• Neuronal α7 Nicotinic Receptors as a Target for the Treatment of Schizophrenia.

  2015cites this paper
• Altered hippocampal plasticity by prenatal kynurenine administration, kynurenine-3-monoxygenase (KMO) deletion or galantamine

  2015influential citation
• Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology

  2015cites this paper
• The multiple roles of the α7 nicotinic acetylcholine receptor in modulating glutamatergic systems in the normal and diseased nervous system.

  2015cites this paper
• Absence of aryl hydrocarbon receptors increases endogenous kynurenic acid levels and protects mouse brain against excitotoxic insult and oxidative stress

  2015cites this paper
• Targeting of NMDA receptors in new treatments for schizophrenia

  2014cites this paper
• Interactions Between Prenatal Kynurenic Acid Exposure and Adolescent Brain Development in the Emergence of Cognitive Deficits in Schizophrenia

  2014influential citation
• Dysregulation of the kynurenine pathway in psychotic disorders : immunological aspects

  2014cites this paper
• Influence of kynurenine 3-monooxygenase (KMO) gene polymorphism on cognitive function in schizophrenia.

  2014cites this paper
• Potential role of the combination of galantamine and memantine to improve cognition in schizophrenia.

  2014cites this paper
• A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats.

  2014influential citation
• Impaired working memory by repeated neonatal MK-801 treatment is ameliorated by galantamine in adult rats.

  2014cites this paper
• Continuous kynurenine administration during the prenatal period, but not during adolescence, causes learning and memory deficits in adult rats

  2014cites this paper
• Behavioral disturbances in adult mice following neonatal virus infection or kynurenine treatment--role of brain kynurenic acid.

  2014cites this paper
• Cytokines and the neurodevelopmental basis of mental illness

  2013cites this paper
• Importance of the nicotinic acetylcholine receptor system in the prefrontal cortex.

  2013cites this paper
• Changes in synaptic transmission and protein expression in the brains of adult offspring after prenatal inhibition of the kynurenine pathway.

  2013cites this paper
• Perinatal complications and schizophrenia: involvement of the immune system

  2013cites this paper
• The effect of transient increases in kynurenic acid and quinolinic acid levels early in life on behavior in adulthood: Implications for schizophrenia.

  2013influential citation
• International Journal of Tryptophan Research

  year unknowncites this paper